Literature DB >> 21395187

Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395187

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  28 in total

1.  Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers.

Authors:  Yi-Chun Lai; Kuen-Cheh Yang; Szu-Min Hsieh; Chien-An Yao; Long-Teng Lee; Kuo-Chin Huang
Journal:  Clin Vaccine Immunol       Date:  2012-01-18

2.  Transmission of influenza B viruses in the guinea pig.

Authors:  Natalie Pica; Yi-Ying Chou; Nicole M Bouvier; Peter Palese
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

4.  [Influenza : clinical symptoms, diagnostics and therapy].

Authors:  G G U Rohde
Journal:  Internist (Berl)       Date:  2011-09       Impact factor: 0.743

5.  Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.

Authors:  Andrea Orsi; Giuseppina Maria Elena Colomba; Fanny Pojero; Giuseppe Calamusa; Cristiano Alicino; Cecilia Trucchi; Paola Canepa; Filippo Ansaldi; Francesco Vitale; Fabio Tramuto
Journal:  Hum Vaccin Immunother       Date:  2017-08-03       Impact factor: 3.452

6.  Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines.

Authors:  Yang Zang; Dongchuan Du; Peng Ge; Yongqing Xu; Xintao Liu; Yan Zhang; Weiheng Su; Irina Kiseleva; Larisa Rudenko; Fei Xu; Wei Kong; Chunlai Jiang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Reply to Sullivan and Kelly and Skowronski et al.

Authors:  Arnold S Monto; Suzanne E Ohmit
Journal:  Clin Infect Dis       Date:  2013-04-25       Impact factor: 9.079

8.  Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2011-10-14

9.  Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.

Authors:  David W Scheifele; Shelly A McNeil; Brian J Ward; Marc Dionne; Curtis Cooper; Brenda Coleman; Mark Loeb; Ethan Rubinstein; Janet McElhaney; Todd Hatchette; Yan Li; Emanuele Montomoli; Amy Schneeberg; Julie A Bettinger; Scott A Halperin
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

10.  Increased defibrillator therapies during influenza season in patients without influenza vaccines.

Authors:  Sheldon M Singh; Russell J de Souza; Ramanan Kumareswaran
Journal:  J Arrhythm       Date:  2015-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.